- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Bexarotene safe treatment for early-stage CTCL
Washington - Bexarotene gel appears to be an effective and well-tolerated monotherapy when used as first-line treatment for early-stage cutaneous T-cell lymphoma, Madeleine Duvic, M.D., reported at the annual meeting of the American Academy of Dermatology.
Related Videos
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health
How Mindy Haws, MD, Empowers Women in Aesthetic Medicine
LIMITLESS: A Collaborative Effort Between Allergan, The Aesthetic Society, and The American Society of Plastic Surgeons
How the LIMITLESS Initiative Supports Female Leaders in Dermatology
Aesthetic Treatments: More Than Just Enhancements, A Path to Empowerment
Four Key Factors When Buying Dermatology Devices
Chilukuri’s Approach to Safer Aesthetic Treatments
Zoe Diana Draelos, MD, Talks Cosmeceuticals at Fall Clinical
Matt Leavitt Shares His Pearls for Hair Loss Treatments at Fall Clinical
Tina Alster, MD, Receives Vic Narurkar Aesthetic Lectureship in Aesthetic Innovations
Related Content
